Ana Peleteiro‐Vigil
Universidad de Salamanca(ES)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Cholangiocarcinoma and Gallbladder Cancer Studies, Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis(2018)65 cited
- → Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma(2020)60 cited
- → Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk(2018)44 cited
- → Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment(2020)36 cited
- → Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key(2023)13 cited
- → Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide(2023)11 cited
- → Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma(2020)8 cited
- → The Cantabria Cohort, a protocol for a population-based cohort in northern Spain(2023)6 cited
- → Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3(2024)3 cited
- The ace «As» a venom: the role of arsenic in «The name of the rose»(2017)